MyFinsight
Home
Blog
About
Contact
nams: the balance sheet
Download
Download image
Restricted cash
$1,308K
Marketable securities,
current
$164,539K
Prepayments and other
receivables
$28,074K
Cash and cash
equivalents
$538,407K
Intangible assets
$439K
Operating right of use
asset
$246K
Property, plant and
equipment, net
$323K
Marketable securities, net
of current portion
$53,091K
Total current assets
$732,328K
Total assets
$786,427K
Total liabilities and
shareholders' equity
$786,427K
Total shareholders'
equity
$728,070K
Total liabilities
$58,357K
Accumulated loss
-$687,467K
Accumulated other
comprehensive income
$4,640K
Additional paid-in capital
$1,396,790K
Lease liability, net
of current portion
$85K
Total current
liabilities
$58,272K
Ordinary shares
$14,107K
Derivative warrant
liabilities
$44,361K
Lease liability,
current
$181K
Accrued expenses and
other current...
$10,098K
Accounts payable
$3,632K
Back
Back
Balance Sheet
source: myfinsight.com
NewAmsterdam Pharma Co N.V. (NAMS)
NewAmsterdam Pharma Co N.V. (NAMS)